1-(Oxetan-3-yl)-1h-pyrazole-4-carboxylic acid, 98%, 100mg

Ethyl 2-(4-bromo-3-fluorophenyl)acetate, 97%, 25g

4-(1,2,2,2-Tetrafluoro-1-trifluoromethyl-ethyl)-benzene-1,3-diamine, 1g

Système de vide LABOXACT® SEM série EM 842, 1 pièce

3-(2,4-Difluorophenoxy)azetidine hydrochloride, 98%, 10g

tert-Butyl 2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole-1-carboxylate, 95.0%, 25g

2-((tert-Butoxycarbonyl)amino)isonicotinic acid, 95.0%, 500mg

4-Iodo-1-methylpyrazole>98.0%(GC)1g

tert-Butyl ((3S,4R)-4-aminotetrahydrofuran-3-yl)carbamate, 97%, 250mg

Ethyl 5-nitrofuran-2-carboxylate, 98%, 5g

Fmoc-l-Homophenylalanine, 95.0%, 100g

(1-Bromovinyl)trimethylsilane>96.0%(GC)5g

Aminooxy-PEG2-azide, 250mg